A combination of a DNA-chimera siRNA against PLK-1 and zoledronic acid suppresses the growth of malignant mesothelioma cells in vitro.
スポンサーリンク
概要
- 論文の詳細を見る
Although novel agents effective against malignant mesothelioma (MM) have been developed, the prognosis of patients with MM is still poor. We generated a DNA-chimeric siRNA against polo-like kinase-1 (PLK-1), which was more stable in human serum than the non-chimeric siRNA. The chimeric PLK-1 siRNA inhibited MM cell proliferation through the induction of apoptosis. Next, we investigated the effects of zoledronic acid (ZOL) on MM cells, and found that ZOL also induced apoptosis in MM cells. Furthermore, ZOL augmented the inhibitory effects of the PLK-1 siRNA. In conclusion, combining a PLK-1 siRNA with ZOL treatment is an attractive strategy against MM.
- 2010-08-28
論文 | ランダム
- 特集を終えて…
- 企画趣旨
- 厳しい施工条件を克服した夢咲トンネルの整備
- ダイヤの原石発掘プロジェクト : WiN-Japan ***交流会in自由が丘
- P-258 メトクロプラミド中止により意識障害が改善した 1 症例